STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ACAD ACADIA PHARMACEUTICALS INCORPORATED StockScouter® Report

5

StockScouter® Score

ACADIA PHARMACEUTICALS INCORPORATED, a mid cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • The multi-period measure of relative price change and consistency is well above average. Positive

 

Concerns

  • The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
  • Two or more executives, directors or major shareholders – including one high-level executive –sold a small number of shares recently. Very negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 80% done.
Low
High

Core Model Grades

B
D
D
A

Previous Ratings

5
3
5